Singapore markets close in 5 hours 28 minutes

Straits Times Index
3,301.45
+8.52(+0.26%)
Nikkei
38,236.07
-38.03(-0.10%)
Hang Seng
18,460.33
-15.59(-0.08%)
FTSE 100
8,213.49
+41.34(+0.51%)
Bitcoin USD
63,867.66
+782.95(+1.24%)
CMC Crypto 200
1,326.01
+49.03(+3.84%)

Clinuvel Pharmaceuticals Limited (CUV.XA)

Cboe AU - Cboe AU Real-time price. Currency in AUD

Add to watchlist

15.01

+0.06

(+0.40%)

As of 01:32PM AEST. Market open.

All

Simply Wall St.
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Clinuvel Pharmaceuticals' (ASX:CUV) stock is up by a considerable 8.7% over the past month. Since the market usually...
GlobeNewswire
Photomedicine Pioneer CLINUVEL Unveils Clinical, Cosmetic Ambitions to German Investors
DÜSSELDORF, Germany, March 28, 2024 (GLOBE NEWSWIRE) -- Pioneering biopharmaceutical company CLINUVEL yesterday hosted a wide-ranging market briefing discussing its novel drug SCENESSE® (afamelanotide) and the future of photomedicine. Over 70 guests discussed the Company’s unique history and future growth potential at an invitation-only event in Düsseldorf. Managing Director and CEO, Dr Philippe Wolgen shared the Company’s success in establishing profitability over the past seven financial years
Simply Wall St.
Clinuvel Pharmaceuticals (ASX:CUV) shareholders have endured a 50% loss from investing in the stock three years ago
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Clinuvel Pharmaceuticals...